| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
74,299
|
82,672
|
81,405
|
77,281
| | Cost of Revenue | 37,505 | 40,904 | 40,710 | 38,199 | | |
Gross Profit
|
36,794
|
41,768
|
40,695
|
39,082
| |
|
Operating Expenses |
|
Research Development | 1,903 | 2,220 | 2,988 | 2,729 |
|
Selling General and Administrative | 22,866 | 20,731 | 20,177 | 22,806 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
12,025
|
18,817
|
17,530
|
13,547
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 168 | 125 | 158 | 145 |
|
Earnings Before Interest And Taxes | 12,193 | 18,942 | 17,688 | 13,692 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 12,193 | 18,942 | 17,688 | 13,692 |
|
Income Tax Expense | 3,508 | 6,599 | 5,500 | 4,543 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 8,685 | 12,343 | 12,188 | 9,149 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
8,685
|
12,343
|
12,188
|
9,149
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
8,685
|
12,343
|
12,188
|
9,149
|
|
0.17(0.24%) 10:01AM EDT - Nasdaq Real Time Price